Neuspera Medical announced today that the FDA approved its integrated sacral neuromodulation (iSNM) system. The FDA cleared the system for the treatment of urinary urge incontinence (UUI). San Jose, California-based Neuspera says its system offers an alternative to traditional SNM for UUI. The discreet, non-invasive device received FDA clearance last year for the treatment of chronic […]
NeuSpera Medical
Neuspera has positive sacral neuromod data
Neuspera Medical today announced six-month pivotal clinical trial data highlighting the efficacy of its battery-free percutaneous sacral neuromodulation (pSNM) system. Findings showed comparable efficacy with the pSNM system against traditional sacral neuromodulation (SNM) devices. it also aims to offer a significantly better patient experience for the treatment of urgency urinary incontinence (UUI). San Jose, California-based […]
The top 10 urology device stories of 2024 so far
Urology Week 2024, which closes out The Urology Foundation’s Urology Awareness Month, is a good time to highlight the innovations in this space. This week (Sept. 23-29), is an initiative of the European Association of Urology that brings together national urological societies, urology practitioners, urology nurses, patients and their families, and politicians to create awareness of urological […]
Neuromod tech developer Neuspera appoints first COO
Neuspera Medical announced today that it appointed Bunty Banerjee as its first chief operating officer (COO). The San Jose, California-based sacral neuromodulation (SNM) technology developer said Banerjee will lead activities in R&D and operations while working closely with all other functions. His appointment comes as the company completes a new FDA submission for its neuromodulation […]
7 neurotech companies you need to know
Neurotech is going far beyond just using pacemaker-like devices to treat the brain and nervous system. In recent years, the tech has gotten smaller — and in some cases, even noninvasive. The hope is that the innovation will fuel wider adoption of technologies to treat everything from Alzheimer’s disease to anxiety. Plenty of major medical […]
Neuromod developer Neuspera Medical raises $23M in Series D
Neuspera Medical today announced it raised $23 million in a recent Series D funding round. The San Jose, California-based company’s latest funding round was led by Vertex Ventures and Treo Ventures. Action Potential Venture Capital, Windham Venture Partners, Olympus Innovation Ventures and another strategic investor contributed to the Series D fundraising. Neuspera Medical earmarked the […]
FDA clears Neuspera Medical peripheral nerve stim
Neuspera Medical this week announced its ultra-miniaturized neurostimulator system received FDA clearance. The Neuspera system is a micro-implant that delivers neurostimulation therapy through a wireless platform, including a wearable transmitter and iPad-based clinician programmer. The company designed the system to provide peripheral nerve stimulation (PNS) in an ultra-miniaturized option to allow for a better patient […]
Neuspera Medical appoints new CEO
Implantable neuromodulation technology developer Neuspera Medical announced today that Steffen Hovard joined the company as CEO. Hovard most recently served as president of Coloplast’s interventional urology arm. He had leadership responsibilities across four business areas within urological devices. At Coloplast, he oversaw 900 employees across 19 countries. According to a news release, Hovard also serves […]
Neuspera Medical raises $26m Series B for injectable neuromod device
Neuspera Medical said today that it raised a $26 million Series B round for the injectable neuromodulation devices it’s developing. Formerly known as Vivonda Medical, San Jose, Calif.-based Neuspera said the round was led by 6 Dimensions Capital, joined by all of its Series A investors, including Action Potential Venture Capital and Windham Venture Partners, and new […]
Neuspera closes $9m funding round
NeuSpera Medical closed an $9 million round of equity financing, according to a new SEC filing from the company. NeuSpera, formerly known as Vivonda Medical, is developing injectable neuromodulation devices, so called “electroceuticals,” using licensed mid-field powering technology. The Santa Clara, Calif.-based company says its implantable module is 100 times smaller than other neuromodulation devices. […]
NeuSpera raises $8m for injectable neuromod devices
NeuSpera Medical said yesterday it raised $8 million in a new round of equity financing to support its injectable neuromodulation devices. NeuSpera, formerly known as Vivonda Medical, is developing injectable neuromodulation devices, so called “electroceuticals,” using licensed mid-field powering technology. The Santa Clara, Calif.-based company says its implantable module is 100 times smaller than other […]
